VentriPoint Diagnostics Ltd V.VPT

Alternate Symbol(s): VPTDF

Healthcare Medical Devices

Ventripoint Diagnostics Ltd is a Canada-based medical device company. The Company is engaged in the development and commercialization of diagnostic tools that monitor patients with heart disease. It is developing a suite of applications for all heart diseases and imaging modalities, including congenital heart disease, pregnancy, pulmonary hypertension, COVID-19, imaging, and cardiotoxicity in oncology patients. The Company’s Ventripoint Medical System (VMS+) is a diagnostic aid that was developed to provide a point-of-care solution to better communicate the heart’s structure and function without the need for magnetic resonance imaging (MRI). VMS+ enhances ultrasound, providing three-dimensional (3D) technology that allows for visualization of all four chambers of the heart. The system’s proprietary Knowledge Based Reconstruction (KBR) technology creates 3D models of the heart and calculates volumes and ejection fractions equivalent to the gold-standard Magnetic resonance imaging (MRI).

TSXV:VPT - Post by User

VentriPoint Diagnostics Ltd

Bullboard Posts

Comment by bullboardmonkeyon Jun 02, 2016 3:51pm

75 Views

Post# 24928465

RE:Nice of GA to cut warrant holders a deal (again)

niner - it's a real market confidence builder to know that the company in the future will be sustaining itself on drastically discounted warrants rather than actual sales of units. Doesn't everyone in the world want our device? Oh, excuse me, I forgot, everyone in the world is waiting for the 4-chamber version that will be ready in 4 years. (18 months - yeah right!)

Bullboard Posts

Yukon agency detects cyanide near Victoria Gold's Eagle mine